美圖(01357.HK)發布AI視覺大模型MiracleVision 股價曾升17%
美圖(01357.HK)公布,第二屆美圖影像節於今日(19日)舉行,本屆影像節主題為「AI時代的影像生產力工具」。公司將在發布會上發布7款新產品,從生活娛樂場景拓展到生產力場景,涉及設計、視頻生產等多個專業領域。
據悉,美圖將發布「懂美學的AI視覺大模型」MiracleVision,為行業客戶提供AI視覺解決方案,並與創作者和開發者共建模型生態。
美圖午後曾炒高17.4%,高見2.76元,現報2.69元,升14.47%,成交1.55億股,涉資3.84億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.